Nature CommunicationsKat5 deficiency in alveolar type II cells licenses STAT6-driven glycolytic reprogramming and pulmonary fibrosisYoujing YangYi LingJianzhong LiQianmin LiYanmei FengJun XiaoYu MaShasha Tao2026-07-03Full textDOI https://doi.org/10.1038/s41467-026-75317-w